C. Ferreccio

发表

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

M. Levine, C. Ferreccio, S. Cryz, 1990, The Lancet.

LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION

R. Black, MyronM. Levine, R. Germanier, 1987, The Lancet.

Progress in vaccines against typhoid fever.

M. Levine, C. Tacket, R. Black, 1989, Reviews of infectious diseases.

Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.

M. Levine, C. Tacket, S. Cryz, 1990, Research in microbiology.

Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.

M. Levine, S. Cryz, E. Ortiz, 1999, Vaccine.

Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.

M. Levine, H. Rodríguez, C. Ferreccio, 1989, The Journal of infectious diseases.

Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.

M. Levine, C. Meschievitz, B. Fritzell, 1993, The Pediatric infectious disease journal.

Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.

M. Levine, K. Edwards, J. Clemens, 1992, JAMA.

The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.

M. Levine, J. Clemens, L. Avila, 1991, The Pediatric infectious disease journal.

Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile.

M. Levine, P. Abrego, V. Prado, 1991, American journal of epidemiology.

Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile.

D. Maneval, M. Levine, H. Lior, 1993, American journal of epidemiology.

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee.

M. Levine, R. Black, C. Lanata, 1990, Vaccine.

Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

O. Levine, R. Lagos, P. Vial, 1993, American journal of epidemiology.

A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile.

M. Levine, J. Clemens, E. Ortiz, 1990, The Pediatric infectious disease journal.

Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers

M. Levine, G. Losonsky, J. Robbins, 1987, Journal of clinical microbiology.

Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years.

M. Levine, R. Black, D. Bulas, 1984, The Journal of pediatrics.

Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.

M. Levine, G. Losonsky, S. Svenson, 1987, The Journal of infectious diseases.

STUDIES TO CONTROL ENDEMIC TYPHOID FEVER

H. M.P., C. Ferreccio, Stephen Sears, 2022 .

Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors

M. Levine, J. Morris, R. Robins-Browne, 1991, Journal of clinical microbiology.

Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.

M. Levine, J. Morris, G. Drusano, 1988, The Journal of infectious diseases.

Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing.

M. Levine, J. Morris, R. Black, 1986, The American journal of tropical medicine and hygiene.

Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.

Rosanna Lagos, M. Levine, W. Blackwelder, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Typhoid vaccines come of age

M. Levine, David N. Taylor, C. Ferreccio, 1989, The Pediatric infectious disease journal.

Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

M. Levine, J. Murphy, S. Wasserman, 1989, Clinical and experimental immunology.

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.

M. Levine, C. Tacket, J. Robbins, 1986, The Journal of infectious diseases.

Immunogenicity of Salmonella typhi Ty21a vaccine for young children

M. Levine, G. Losonsky, J. Olson, 1991, Infection and immunity.

The current status of typhoid vaccine development and clinical trials with typhoid vaccines.

M. Levine, C. Tacket, G. Losonsky, 1988, Southeast Asian Journal of Tropical Medicine and Public Health.

The use of Moore swabs for isolation of Salmonella typhi from irrigation water in Santiago, Chile.

M. Levine, R. Black, B. Rowe, 1984, The Journal of infectious diseases.

Typhoid fever in Santiago, Chile: a study of household contacts of pediatric patients.

M. Levine, J. Morris, R. Black, 1984, The American journal of tropical medicine and hygiene.

Studies to Control Endemic Typhoid Fever in Chile

M. Levine, C. Ferreccio, 1987 .

Sensitivity of Moore sewer swabs for isolating Salmonella typhi

M. Levine, S. Sears, C. Ferreccio, 1986, Applied and environmental microbiology.

Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission.

J. Morris, C. Ferreccio, R. Russell, 1993, The Journal of infectious diseases.

[Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].

G. Losonsky, J. Kaper, S. Cryz, 1993, Revista medica de Chile.